Ironwood Capital
Ironwood Capital is a private equity firm based in Avon, Connecticut, with additional offices in Boston and Birmingham, that provides non-controlling growth capital to middle-market companies across North America. The firm mainly uses subordinated debt and preferred equity to support growth financings, recapitalizations, generational transitions, expansions, and buyouts, with typical investment sizes ranging from several million dollars to the low tens of millions and the capacity to participate in larger transactions with co-investors. It maintains a broad, industry-agnostic approach across sectors such as manufacturing, environmental and waste services, transportation and logistics, business services, healthcare, and consumer industries. Investments are generally structured to preserve management ownership and involve minority or non-controlling stakes, with opportunities for equity co-investment. The firm aims for an exit in roughly three to five years and pursues a nationwide scope rather than being tied to a single sector or geography.
Past deals in Connecticut
Torigen Pharmaceuticals
Venture Round in 2022
Founded in 2013, Torigen Pharmaceuticals specializes in developing innovative cancer care solutions for pets. Based in Farmington, Connecticut, the company focuses on advancing scientific research to bring novel approaches to companion animal cancers.
P2 Science
Series C in 2020
Founded in 2009 by Yale scientists and a chemical industry veteran, P2 Science is a venture-backed company specializing in renewable specialty chemicals. It converts renewable feedstocks like vegetable oils into high-value products such as flavor, fragrance, and cosmetics ingredients, serving diverse markets including food, personal care, and industrial cleaning.
IsoPlexis
Series C in 2020
IsoPlexis is a life science technology company based in Branford, Connecticut, established in 2013. It specializes in developing a single-cell detection system that identifies a wide array of patient immune responses at the single-cell level. The company's platform focuses on cell-based proteomic systems and biomarkers, allowing for the assessment of therapeutic safety and efficacy, monitoring of disease progression, and exploration of functional protein biology and cellular signaling networks. IsoPlexis's technology enables clients to predict cancer patient responses to various novel immunotherapies and cellular therapies, thereby enhancing therapeutic development and informing clinical decision-making.
PayVeris
Series D in 2019
PayVeris, LLC is a cloud-based digital payment and money transfer platform that provides comprehensive solutions for both consumer and business bill payments, as well as external account-to-account transfers between various financial institutions. Founded in 2011 and headquartered in Cromwell, Connecticut, PayVeris enables person-to-person payments, allowing users to send money electronically from their bank or credit union accounts via web, smartphone, or tablet. The platform includes PayWatch, an integrated fraud prevention solution that monitors transactions for potential risks, and PayItNow, a service that connects financial institutions, merchants, and consumers in the payments process. PayVeris has established strategic partnerships with Kony and Corelation to enhance its offerings and expand its reach in the digital payments landscape.
IsoPlexis
Series C in 2019
IsoPlexis is a life science technology company based in Branford, Connecticut, established in 2013. It specializes in developing a single-cell detection system that identifies a wide array of patient immune responses at the single-cell level. The company's platform focuses on cell-based proteomic systems and biomarkers, allowing for the assessment of therapeutic safety and efficacy, monitoring of disease progression, and exploration of functional protein biology and cellular signaling networks. IsoPlexis's technology enables clients to predict cancer patient responses to various novel immunotherapies and cellular therapies, thereby enhancing therapeutic development and informing clinical decision-making.
IsoPlexis
Series B in 2017
IsoPlexis is a life science technology company based in Branford, Connecticut, established in 2013. It specializes in developing a single-cell detection system that identifies a wide array of patient immune responses at the single-cell level. The company's platform focuses on cell-based proteomic systems and biomarkers, allowing for the assessment of therapeutic safety and efficacy, monitoring of disease progression, and exploration of functional protein biology and cellular signaling networks. IsoPlexis's technology enables clients to predict cancer patient responses to various novel immunotherapies and cellular therapies, thereby enhancing therapeutic development and informing clinical decision-making.
P2 Science
Series B in 2017
Founded in 2009 by Yale scientists and a chemical industry veteran, P2 Science is a venture-backed company specializing in renewable specialty chemicals. It converts renewable feedstocks like vegetable oils into high-value products such as flavor, fragrance, and cosmetics ingredients, serving diverse markets including food, personal care, and industrial cleaning.
Precipio Diagnostics
Series B in 2013
Precipio Diagnostics is a cancer diagnostics company based in New Haven, Connecticut, specializing in clinical diagnostic services for hematopoietic cancers. The company offers advanced diagnostic products, including the HemeScreen panel for genetic mutation testing and the IV-Cell media, which enhances the accuracy of laboratory results. Precipio serves a diverse clientele, including oncologists, hospitals, reference laboratories, and pharmaceutical companies. In its commitment to improving cancer care, the company collaborates with prominent academic institutions such as the Yale School of Medicine and Dana-Farber Cancer Institute, fostering connections between physicians and leading pathologists. With laboratories in New Haven and Omaha, Precipio aims to reduce instances of cancer misdiagnoses and provide essential diagnostics to oncologists across the United States.
PayVeris
Venture Round in 2013
PayVeris, LLC is a cloud-based digital payment and money transfer platform that provides comprehensive solutions for both consumer and business bill payments, as well as external account-to-account transfers between various financial institutions. Founded in 2011 and headquartered in Cromwell, Connecticut, PayVeris enables person-to-person payments, allowing users to send money electronically from their bank or credit union accounts via web, smartphone, or tablet. The platform includes PayWatch, an integrated fraud prevention solution that monitors transactions for potential risks, and PayItNow, a service that connects financial institutions, merchants, and consumers in the payments process. PayVeris has established strategic partnerships with Kony and Corelation to enhance its offerings and expand its reach in the digital payments landscape.
The Green Life Guides
Private Equity Round in 2011
The Green Life Guides, LLC operates an online site for wedding ideas, products, and services. Its products and services include business cards, live events, food and flowers, and service directory for vendors; products and gifts for weddings, bar mitzvahs, and holidays; living room furniture; table linens and flatware; appliances and electronics, baking, cleaning supplies, cookware, and cutting boards; baskets, rugs, candles and candle holders, centerpieces, curtains, and hardware; organization and storage products; blankets, quilts, duvets, sheets, mattresses, pillows, and accents; towels, bathroom accessories, rugs and mats, shower curtains, and personal care and beauty products; garden accessories, composters, and plants and seeds; and dog and cat supplies. The company was founded in 2007 and is based in New Haven, Connecticut.
Floop
Seed Round in 2011
Floop, Inc. operates as a mobile application that offers real time graphical interface. The company was incorporated in 2010 and is based in Woodbridge, Connecticut.
NovaTract Surgical
Seed Round in 2011
NovaTract Surgical, Inc. is a medical device company dedicated to enhancing minimally invasive surgical practices. Founded in 2010 and based in Madison, Connecticut, the company specializes in developing innovative solutions such as the NovaGrasp, a single-use laparoscopic grasper for tissue and organ retraction, and the NovaTract, a dynamic retractor designed for various surgical fields including colorectal, urologic, gynecologic, and robotic-assisted procedures. NovaTract Surgical aims to address the needs of the rapidly evolving fields of single-incision laparoscopic surgery and natural orifice transluminal endoscopic surgery, providing healthcare institutions with advanced tools to improve surgical outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.